Share on Facebook Share on Twitter Email
Answers.com

Elvucitabine

 
Wikipedia: Elvucitabine
Elvucitabine
Systematic (IUPAC) name
4-Amino-5-fluoro-1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one
Identifiers
CAS number 181785-84-2
ATC code none
PubChem 469717
Chemical data
Formula C9H10FN3O3 
Mol. mass 227.19 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Elvucitabine is an experimental nucleoside reverse transcriptase inhibitor (NRTI), developed by Achillion Pharmaceuticals, Inc. for the treatment of HIV.

Currently, it is in Phase II clinical trials.[1]

References



Search unanswered questions...
Enter a question here...
Search: All sources Community Q&A Reference topics
 
 
Learn More
Achillion Pharmaceuticals In
Trizivir
Tenofovir/emtricitabine

Post a question - any question - to the WikiAnswers community:

 

Copyrights:

Wikipedia. This article is licensed under the Creative Commons Attribution/Share-Alike License. It uses material from the Wikipedia article "Elvucitabine" Read more